145 related articles for article (PubMed ID: 9263125)
1. Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the ras-binding domain of the raf-p74 protein, identified from molecular dynamics calculations.
Chung D; Amar S; Glozman A; Chen JM; Friedman FK; Robinson R; Monaco R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
J Protein Chem; 1997 Aug; 16(6):631-5. PubMed ID: 9263125
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics on complexes of ras-p21 and its inhibitor protein, rap-1A, bound to the ras-binding domain of the raf-p74 protein: identification of effector domains in the raf protein.
Chen JM; Monaco R; Manolatos S; Brandt-Rauf PW; Friedman FK; Pincus MR
J Protein Chem; 1997 Aug; 16(6):619-29. PubMed ID: 9263124
[TBL] [Abstract][Full Text] [Related]
3. Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway.
Chie L; Amar S; Kung HF; Lin MC; Chen H; Chung DL; Adler V; Ronai Z; Friedman FK; Robinson RC; Kovac C; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Cancer Chemother Pharmacol; 2000; 45(6):441-9. PubMed ID: 10854130
[TBL] [Abstract][Full Text] [Related]
4. Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signaling.
Chen JM; Rijhwani K; Friedman FK; Hyde MJ; Pincus MR
J Protein Chem; 2000 Oct; 19(7):545-51. PubMed ID: 11233167
[TBL] [Abstract][Full Text] [Related]
5. The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein.
Qu Y; Adler V; Izotova L; Pestka S; Bowne W; Michl J; Boutjdir M; Friedman FK; Pincus MR
Front Biosci; 2007 Sep; 12():5089-97. PubMed ID: 17569632
[TBL] [Abstract][Full Text] [Related]
6. Computed three-dimensional structures for the ras-binding domain of the raf-p74 protein complexed with ras-p21 and with its suppressor protein, rap-1A.
Chen JM; Manolatos S; Brandt-Rauf PW; Murphy RB; Monaco R; Pincus MR
J Protein Chem; 1996 Aug; 15(6):511-8. PubMed ID: 8895097
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ras-induced oocyte maturation by peptides from ras-p21 and GTPase activating protein (GAP) identified as being effector domains from molecular dynamics calculations.
Friedman FK; Chie L; Chung D; Robinson R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
J Protein Chem; 2002 Jul; 21(5):361-6. PubMed ID: 12206510
[TBL] [Abstract][Full Text] [Related]
8. Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation.
Kovac C; Clie L; Morin J; Friedman FK; Robinson R; Chung DL; Kanovsky M; Flom J; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Cancer Chemother Pharmacol; 2001 Jul; 48(1):9-14. PubMed ID: 11488531
[TBL] [Abstract][Full Text] [Related]
9. Two dual specificity kinases are preferentially induced by wild-type rather than by oncogenic RAS-P21 in Xenopus oocytes.
Qu Y; Adler V; Chu T; Platica O; Michl J; Pestka S; Izotova L; Boutjdir M; Pincus MR
Front Biosci; 2006 Sep; 11():2420-7. PubMed ID: 16720323
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21.
Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
J Protein Chem; 1999 Nov; 18(8):875-9. PubMed ID: 10839624
[TBL] [Abstract][Full Text] [Related]
11. A peptide from the GAP-binding domain of the ras-p21 protein and azatyrosine block ras-induced maturation of Xenopus oocytes.
Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
Anticancer Res; 1991; 11(4):1373-8. PubMed ID: 1746893
[TBL] [Abstract][Full Text] [Related]
12. Differences in patterns of activation of MAP kinases induced by oncogenic ras-p21 and insulin in oocytes.
Ranginwale M; Smith S; Flom J; Chie L; Kanovsky M; Chung D; Friedman FK; Robinson RC; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Exp Cell Res; 2001 Sep; 269(1):162-9. PubMed ID: 11525649
[TBL] [Abstract][Full Text] [Related]
13. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
[TBL] [Abstract][Full Text] [Related]
14. Identification of the site of inhibition of oncogenic ras-p21-induced signal transduction by a peptide from a ras effector domain.
Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
J Protein Chem; 1999 Nov; 18(8):881-4. PubMed ID: 10839625
[TBL] [Abstract][Full Text] [Related]
15. Development of new anti-cancer peptides from conformational energy analysis of the oncogenic ras-p21 protein and its complexes with target proteins.
Pincus MR
Front Biosci; 2004 Sep; 9():3486-509. PubMed ID: 15353372
[TBL] [Abstract][Full Text] [Related]
16. A peptide from the GAP-binding domain of the ras-p21 protein as well as azatyrosine block ras-induced maturation of Xenopus oocytes.
Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
Biochem Biophys Res Commun; 1991 Dec; 181(3):1378-84. PubMed ID: 1764089
[TBL] [Abstract][Full Text] [Related]
17. Identification of the site of inhibition of mitogenic signaling by oncogenic ras-p21 by a ras effector peptide.
Chie L; Friedman FK; Kung HF; Lin MC; Chung D; Pincus MR
J Protein Chem; 2002 Jul; 21(5):367-70. PubMed ID: 12206511
[TBL] [Abstract][Full Text] [Related]
18. Raf-1 N-terminal sequences necessary for Ras-Raf interaction and signal transduction.
Pumiglia K; Chow YH; Fabian J; Morrison D; Decker S; Jove R
Mol Cell Biol; 1995 Jan; 15(1):398-406. PubMed ID: 7799948
[TBL] [Abstract][Full Text] [Related]
19. A protein methyl transferase, PRMT5, selectively blocks oncogenic ras-p21 mitogenic signal transduction.
Chie L; Cook JR; Chung D; Hoffmann R; Yang Z; Kim Y; Pestka S; Pincus MR
Ann Clin Lab Sci; 2003; 33(2):200-7. PubMed ID: 12817625
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics.
Chen JM; Brandt-Rauf PW; Pincus MR
J Biomol Struct Dyn; 1996 Jun; 13(6):925-33. PubMed ID: 8832375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
